{
  "meta": {
    "title": "22_Autoimmune_Disorders_Of_Hepatobiliary_System",
    "url": "https://brainandscalpel.vercel.app/22-autoimmune-disorders-of-hepatobiliary-system-4495ac0c.html",
    "scrapedAt": "2025-11-30T12:28:30.479Z"
  },
  "questions": [
    {
      "text": "Autoimmune hepatitis is suspected in a woman presenting with fatigue, pruritus, and arthralgia. She has a past history of Hashimoto's thyroiditis. Which of the following is not part of the simplified scoring system for the given condition?",
      "choices": [
        {
          "id": 1,
          "text": "ANA"
        },
        {
          "id": 2,
          "text": "Typical histological features"
        },
        {
          "id": 3,
          "text": "Elevated IgG"
        },
        {
          "id": 4,
          "text": "Presence of viral markers"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Presence of viral markers is not a part of the simplified scoring system for diagnosis of autoimmune hepatitis.</p>\n<p>The <strong>simplified scoring system</strong> includes four variables. They are:</p>\n<ol>\n<li>Autoantibodies</li>\n<li>Elevated serum IgG level</li>\n<li>Typical compatible histologic features</li>\n<li>Absence of viral hepatitis markers</li>\n</ol>\n<p>The <strong>clinical presentation</strong> in autoimmune hepatitis is variable and shares features with <strong>acute and chronic hepatitis</strong> of other aetiologies. They usually present with an <strong>insidious onset</strong> of non-specific symptoms such as fatigue, anorexia and eventually jaundice. It can then progress to extensive <strong>liver necrosis and liver failure.</strong></p>\n<p>Autoimmune hepatitis is associated with several <strong>autoimmune diseases</strong> such as:</p>\n<ul>\n<li>Rheumatoid arthritis</li>\n<li>Systemic lupus erythematosus</li>\n<li>Thyroiditis and Grave's disease</li>\n<li>Haemolytic anemia</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA8692",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following drugs is associated with Autoimmune hepatitis (AIH)?",
      "choices": [
        {
          "id": 1,
          "text": "Minocycline"
        },
        {
          "id": 2,
          "text": "5 Aminosalicylic acid"
        },
        {
          "id": 3,
          "text": "Piroxicam"
        },
        {
          "id": 4,
          "text": "Nitroglycerine"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Minocycline</strong> is associated with the development of drug-induced AIH.</p>\n<p>Other drugs associated with AIH include <strong>nitrofurantoin</strong>, methyldopa, diclofenac, and possibly statins.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0846",
      "difficulty": "hard"
    },
    {
      "text": "A 20-year-old lady is suspected to have autoimmune hepatitis. Which of the following antibodies is unlikely to be present in her serum?",
      "choices": [
        {
          "id": 1,
          "text": "Cytoplasmic antineutrophil cytoplasmic antibodies (cANCA)"
        },
        {
          "id": 2,
          "text": "Antinuclear antibody (ANA)"
        },
        {
          "id": 3,
          "text": "Smooth muscle antibody(SMA)"
        },
        {
          "id": 4,
          "text": "Anti-soluble liver antigen (SLA)"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>cANCA is not seen in <strong>autoimmune hepatitis</strong>. It is positive in Wegner's granulomatosis. <strong>pANCA</strong> is what is seen in autoimmune hepatitis.</p>\n<p>There are 2 types of autoimmune hepatitis:</p>\n<p><strong>Type I (classic) </strong>autoimmune hepatitis is often seen in <strong>young women. </strong>It is linked to <strong>HLA-DR3 or HLA-DR4</strong>. It responds well to steroids&nbsp;and has a better prognosis. The autoantibodies that are seen in type I are:</p>\n<ul>\n<li>ANA - antinuclear antibodies</li>\n<li>ASMA - anti-smooth muscle actin</li>\n<li>pANCA - perinuclear anti-neutrophil cytoplasmic</li>\n<li>anti-SLA - anti-soluble liver antigen</li>\n</ul>\n<p><strong>Type II </strong>autoimmune hepatitis is often seen in <strong>children.</strong>&nbsp;It is linked to <strong>HLA-DRB1 or HLA-DQB1.&nbsp;</strong>It usually leads to fibrosis, cirrhosis and liver failure. The autoantibodies that are seen in type II are:</p>\n<ul>\n<li>Anti-LKM 1 - anti-liver kidney microsomes</li>\n<li>Anti-liver cytosol 1</li>\n</ul><hr><h3>Related Pearl: Antibodies in Hepatitis</h3><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Antibodies </strong></td>\n<td><strong>Seen in </strong></td>\n</tr>\n<tr>\n<td>\n<p>ANA, ASMA, pANCA, anti-SLA/LP, AMA</p>\n</td>\n<td>\n<p>Autoimmune hepatitis Type 1</p>\n</td>\n</tr>\n<tr>\n<td>Anti-liver cytosol 1</td>\n<td>\n<p>Autoimmune hepatitis Type 2</p>\n</td>\n</tr>\n<tr>\n<td>Anti-LKM 1</td>\n<td>\n<p>Autoimmune hepatitis Type 2&nbsp;</p>\n<p>Chronic hepatitis C</p>\n</td>\n</tr>\n<tr>\n<td>Anti-LKM 2</td>\n<td>Drug-induced hepatitis</td>\n</tr>\n<tr>\n<td>Anti-LKM 3</td>\n<td>\n<p>Chronic hepatitis D</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li>ANA: Anti-nuclear antibodies (most common antibody in autoimmune hepatitis)</li>\n<li>LKM: Liver&ndash;kidney microsomes</li>\n<li>SLA/LP: Soluble liver antigen/liver-pancreas</li>\n<li>ASMA: Anti-smooth muscle actin</li>\n<li>pANCA: Perinuclear anti-neutrophil cytoplasmic antibodies</li>\n<li>AMA: Antimitochondrial antibodies</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA8687",
      "difficulty": "medium"
    },
    {
      "text": "Match the following:<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td>A. Anti-LKM 1</td>\n<td>i. Autoimmune hepatitis ll</td>\n</tr>\n<tr>\n<td>B. Anti-SLA</td>\n<td>ii. Drug-induced hepatitis</td>\n</tr>\n<tr>\n<td>\n<p>C. Anti-LKM 2</p>\n</td>\n<td>iii. Autoimmune hepatitis l</td>\n</tr>\n<tr>\n<td>D. Anti-LKM 3</td>\n<td>iv. Chronic hepatitis D</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "A-i , B-iii , C-ii , D-iv"
        },
        {
          "id": 2,
          "text": "A-iv , B-ii , C-iii , D-i"
        },
        {
          "id": 3,
          "text": "A-ii , B-iii , C-i , D-iv"
        },
        {
          "id": 4,
          "text": "A-i , B-iii , C-iv , D-ii"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<ul>\n<li>Anti LKM 1- Autoimmune hepatitis II &nbsp;</li>\n<li>Anti SLA - Autoimmune hepatitis I</li>\n<li>Anti LKM 2 - Drug-induced hepatitis &nbsp;</li>\n<li>Anti LKM 3 - Chronic hepatitis D</li>\n</ul><hr><h3>Related Pearl: Antibodies in Hepatitis</h3><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Antibodies </strong></td>\n<td><strong>Seen in </strong></td>\n</tr>\n<tr>\n<td>\n<p>ANA, ASMA, pANCA, anti-SLA/LP, AMA</p>\n</td>\n<td>\n<p>Autoimmune hepatitis Type 1</p>\n</td>\n</tr>\n<tr>\n<td>Anti-liver cytosol 1</td>\n<td>\n<p>Autoimmune hepatitis Type 2</p>\n</td>\n</tr>\n<tr>\n<td>Anti-LKM 1</td>\n<td>\n<p>Autoimmune hepatitis Type 2&nbsp;</p>\n<p>Chronic hepatitis C</p>\n</td>\n</tr>\n<tr>\n<td>Anti-LKM 2</td>\n<td>Drug-induced hepatitis</td>\n</tr>\n<tr>\n<td>Anti-LKM 3</td>\n<td>\n<p>Chronic hepatitis D</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li>ANA: Anti-nuclear antibodies (most common antibody in autoimmune hepatitis)</li>\n<li>LKM: Liver&ndash;kidney microsomes</li>\n<li>SLA/LP: Soluble liver antigen/liver-pancreas</li>\n<li>ASMA: Anti-smooth muscle actin</li>\n<li>pANCA: Perinuclear anti-neutrophil cytoplasmic antibodies</li>\n<li>AMA: Antimitochondrial antibodies</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0848",
      "difficulty": "easy"
    },
    {
      "text": "A 24-year-old woman presenting with abdominal pain is diagnosed with autoimmune hepatitis. The mainstay of management in this patient is:",
      "choices": [
        {
          "id": 1,
          "text": "Glucocorticoids"
        },
        {
          "id": 2,
          "text": "Azathioprine"
        },
        {
          "id": 3,
          "text": "Mycophenolate mofetil"
        },
        {
          "id": 4,
          "text": "Methotrexate"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The mainstay of management in autoimmune hepatitis is <strong>glucocorticoid therapy.</strong></p>\n<p><strong>Glucocorticoids</strong> are started at high doses and tapered down to a low maintenance dose.&nbsp;The dose of glucocorticoids is often reduced by combining with <strong>azathioprine</strong>.</p>\n<p>The benefits of glucocorticoid + azathioprine combination therapy are:</p>\n<ul>\n<li>Reduction in the <strong>duration</strong> of therapy.</li>\n<li>Avoid life-threatening <strong>complications</strong> of steroids (e.g., cushingoid features, hypertension, diabetes, osteoporosis).</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA8695",
      "difficulty": "medium"
    },
    {
      "text": "A 23-year-old female patient with a diagnosis of autoimmune hepatitis did not respond well to glucocorticoids. Which among the following is false regarding her further management options?",
      "choices": [
        {
          "id": 1,
          "text": "Increase the dose  of glucocorticoids"
        },
        {
          "id": 2,
          "text": "Glucocorticoids with high dose azathioprine"
        },
        {
          "id": 3,
          "text": "Switch to Mycophenolate mofetil"
        },
        {
          "id": 4,
          "text": "Liver transplant is contraindicated"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Liver transplant is not contraindicated</strong> in refractory autoimmune hepatitis even though the risk of recurrence is high.</p>\n<p>The medical management of refractory autoimmune hepatitis include:</p>\n<ul>\n<li>High dose glucocorticoids</li>\n<li>Glucocorticoids + high dose azathioprine</li>\n<li>Addition of cyclosporine, tacrolimus, or mycophenolate mofetil.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA8699",
      "difficulty": "medium"
    },
    {
      "text": "A young lady has been on treatment for autoimmune hepatitis for 2 weeks, she has now come for follow-up investigations. Which of the following suggests a poor prognosis in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Bridging necrosis"
        },
        {
          "id": 2,
          "text": "Decreased globulins"
        },
        {
          "id": 3,
          "text": "Increased serum bilirubin"
        },
        {
          "id": 4,
          "text": "Increased serum albumin"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Persistently <strong>increased serum bilirubin</strong> after 2 weeks of therapy suggests a poor prognosis.</p>\n<p>Early signs of poor prognosis include:</p>\n<ul>\n<li>Failure of serum bilirubin to reduce after 2 weeks of therapy.</li>\n</ul>\n<p>Early signs of good prognosis include:</p>\n<ul>\n<li>An increase in serum albumin.</li>\n<li>A decrease in serum bilirubin, globulins and aminotransferases.</li>\n<li>Improvement of symptoms.</li>\n</ul>\n<p>Histopathologic improvement can often take months to years.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0843",
      "difficulty": "hard"
    },
    {
      "text": "The most common symptom of primary biliary cholangitis (PBC) is",
      "choices": [
        {
          "id": 1,
          "text": "Pruritus"
        },
        {
          "id": 2,
          "text": "Fatigue"
        },
        {
          "id": 3,
          "text": "Jaundice"
        },
        {
          "id": 4,
          "text": "Right upper quadrant pain"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The <strong>most common symptom</strong> of&nbsp;primary biliary cholangitis(PBC) is <strong>fatigue</strong>.</p>\n<p>Primary biliary cholangitis(PBC) is a granulomatous autoimmune condition characterized by the destruction of interlobular hepatic bile ducts.&nbsp;</p>\n<p><strong>Most patients</strong> with PBC are <strong>asymptomatic</strong> at the time of the diagnosis. Fatigue and pruritus are both common presenting symptoms. However, the most common symptom is fatigue.</p>\n<p>Other symptoms and signs are -</p>\n<ul>\n<li>Right upper quadrant pain</li>\n<li>Hyperpigmentation&nbsp;</li>\n<li>Xanthomas and xanthelasma&nbsp;</li>\n<li>Jaundice</li>\n<li>Hepatosplenomegaly.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1224",
      "difficulty": "medium"
    },
    {
      "text": "A 44-year-old woman with rheumatoid arthritis is now diagnosed with primary biliary cholangitis. Which of the following is false regarding her lab values?",
      "choices": [
        {
          "id": 1,
          "text": "Positive Anti-LKM- 2 antibodies"
        },
        {
          "id": 2,
          "text": "Elevated alkaline phosphatase  (ALP)"
        },
        {
          "id": 3,
          "text": "Elevated gamma-glutamyl transferase (GGT)"
        },
        {
          "id": 4,
          "text": "Positive antimitochondrial antibodies"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Anti-LKM 2 antibodies are not seen in primary biliary cholangitis. They are seen in drug-induced hepatitis.</p>\n<p>The laboratory findings of primary biliary cholangitis include :</p>\n<ul>\n<li>Liver function tests\n<ul>\n<li><strong>Elevated ALP</strong>&nbsp;</li>\n<li>Elevated GGT and 5'- nucleotidase</li>\n<li>Elevated ALT and AST</li>\n</ul>\n</li>\n<li>Serology -&nbsp;\n<ul>\n<li><strong>Antimitochondrial antibodies</strong> - positive in 95% of patients. These are mostly directed against the pyruvate dehydrogenase complex.</li>\n<li>Antinuclear antibodies</li>\n</ul>\n</li>\n<li>Elevated HDL, LDL, and VLDL</li>\n<li>Elevated serum IgM</li>\n</ul>\n<p>Hyperbilirubinemia is seen once cirrhosis has developed.</p><hr><h3>Related Pearl: Differences between primary sclerosing cholangitis (PSC)  and primary biliary cholangitis (PBC)</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Primary Biliary Cholangitis</strong></td>\n<td><strong>Primary Sclerosing Cholangitis</strong></td>\n</tr>\n<tr>\n<td>Antibodies</td>\n<td>\n<p>Antimitochondrial antibodies positive in most patients</p>\n<p>Antinuclear antibodies positive</p>\n</td>\n<td>\n<div class=\"page\" title=\"Page 860\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Antimitochondrial antibodies /AMA typically negative</p>\n</div>\n</div>\n</div>\n</div>\n<p><strong>p-ANCA</strong>-positive</p>\n</td>\n</tr>\n<tr>\n<td>Age group</td>\n<td>40&ndash;60 years</td>\n<td>30-45 years</td>\n</tr>\n<tr>\n<td>Gender predominance</td>\n<td>Females</td>\n<td>Males</td>\n</tr>\n<tr>\n<td>Site</td>\n<td>Intrahepatic&nbsp;bile ducts only</td>\n<td>Intra- and extrahepatic bile ducts</td>\n</tr>\n<tr>\n<td>&nbsp;Associated with</td>\n<td>\n<p>Sjogren syndrome</p>\n<p>Hashimoto's thyroiditis&nbsp;</p>\n<p>CREST&nbsp;syndrome</p>\n<p>Rheumatoid arthritis</p>\n<p>Celiac disease</p>\n</td>\n<td><strong>Ulcerative colitis</strong></td>\n</tr>\n<tr>\n<td>Diagnosis</td>\n<td>Biopsy</td>\n<td>MRCP/ERCP-strictures&nbsp;</td>\n</tr>\n<tr>\n<td>Biopsy findings</td>\n<td>&nbsp;<strong>Florid duct lesion</strong> (granuloma)</td>\n<td>Concentric \"<strong>onion-skin\"</strong>&nbsp;fibrosis &nbsp; &nbsp;</td>\n</tr>\n<tr>\n<td>Long-term complication</td>\n<td>Cirrhosis</td>\n<td>\n<p>Cirrhosis</p>\n<p>Cholangiocarcinoma</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1219",
      "difficulty": "medium"
    },
    {
      "text": "A patient with a diagnosis of primary biliary cholangitis has been taking ursodeoxycholic acid (UDCA) twice daily. She now presents with ascites and variceal bleeding. What is the most appropriate treatment for this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Initiating methotrexate"
        },
        {
          "id": 2,
          "text": "Continuing ursodeoxycholic acid"
        },
        {
          "id": 3,
          "text": "Add obeticholic acid to the treatment"
        },
        {
          "id": 4,
          "text": "Consider liver transplantation"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The presence of ascites and variceal bleeding suggest <strong>decompensated liver disease</strong> and the appropriate treatment is liver transplantation.&nbsp;</p>\n<p>The <strong>first-line drug</strong> in primary biliary cholangitis is <strong>ursodeoxycholic acid (UDCA)</strong>. It only slows the rate of progression of the disease. It does not provide any symptomatic benefit or cure the disease.</p>\n<p><strong>Obeticholic acid</strong> is another drug used in PBC as monotherapy or in combination with UDCA. It is a <strong>farnesoid X receptor agonist</strong>.</p>\n<p><strong>Liver transplantation</strong> is considered when there are <strong>signs of decompensation or portal hypertension</strong> such as ascites, variceal bleeding, encephalopathy, coagulopathy, or malnutrition.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1208",
      "difficulty": "medium"
    },
    {
      "text": "A middle-aged woman presented with fatigue, pruritis, and xanthomas over the elbows. A biopsy of her bile duct revealed florid duct lesions. What is the diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Klatskin tumor"
        },
        {
          "id": 2,
          "text": "Primary sclerosing cholangitis (PSC)"
        },
        {
          "id": 3,
          "text": "Primary biliary cholangitis (PBC)"
        },
        {
          "id": 4,
          "text": "Intrahepatic cholestasis"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Florid duct lesion</strong> is characteristic of <strong>primary biliary cholangitis (PBC)</strong>. It is the lymphocytes and plasma cells all centered around bile ducts.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9ff3c6f5666749f4a2d2d4e8016ad8ecx400x600.JPEG\" alt=\"Explanation Image\"><p><strong>Primary sclerosing cholangitis</strong> has the characteristic&nbsp; <strong>\"onion-skin\" concentric fibrosis</strong> surrounding the bile ducts.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e75392d5fce54c5d8c8ad5fd37671675x944x746.PNG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Differences between primary sclerosing cholangitis (PSC)  and primary biliary cholangitis (PBC)</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Primary Biliary Cholangitis</strong></td>\n<td><strong>Primary Sclerosing Cholangitis</strong></td>\n</tr>\n<tr>\n<td>Antibodies</td>\n<td>\n<p>Antimitochondrial antibodies positive in most patients</p>\n<p>Antinuclear antibodies positive</p>\n</td>\n<td>\n<div class=\"page\" title=\"Page 860\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Antimitochondrial antibodies /AMA typically negative</p>\n</div>\n</div>\n</div>\n</div>\n<p><strong>p-ANCA</strong>-positive</p>\n</td>\n</tr>\n<tr>\n<td>Age group</td>\n<td>40&ndash;60 years</td>\n<td>30-45 years</td>\n</tr>\n<tr>\n<td>Gender predominance</td>\n<td>Females</td>\n<td>Males</td>\n</tr>\n<tr>\n<td>Site</td>\n<td>Intrahepatic&nbsp;bile ducts only</td>\n<td>Intra- and extrahepatic bile ducts</td>\n</tr>\n<tr>\n<td>&nbsp;Associated with</td>\n<td>\n<p>Sjogren syndrome</p>\n<p>Hashimoto's thyroiditis&nbsp;</p>\n<p>CREST&nbsp;syndrome</p>\n<p>Rheumatoid arthritis</p>\n<p>Celiac disease</p>\n</td>\n<td><strong>Ulcerative colitis</strong></td>\n</tr>\n<tr>\n<td>Diagnosis</td>\n<td>Biopsy</td>\n<td>MRCP/ERCP-strictures&nbsp;</td>\n</tr>\n<tr>\n<td>Biopsy findings</td>\n<td>&nbsp;<strong>Florid duct lesion</strong> (granuloma)</td>\n<td>Concentric \"<strong>onion-skin\"</strong>&nbsp;fibrosis &nbsp; &nbsp;</td>\n</tr>\n<tr>\n<td>Long-term complication</td>\n<td>Cirrhosis</td>\n<td>\n<p>Cirrhosis</p>\n<p>Cholangiocarcinoma</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1229",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements about primary sclerosing cholangitis is false?",
      "choices": [
        {
          "id": 1,
          "text": "Affects both intra and extrahepatic bile ducts"
        },
        {
          "id": 2,
          "text": "Liver biopsy definitively establishes the diagnosis"
        },
        {
          "id": 3,
          "text": "more common in males"
        },
        {
          "id": 4,
          "text": "Leads to development of cholangiocarcinoma"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Liver biopsy does not establish the diagnosis in primary sclerosing cholangitis. The diagnosis requires imaging with MRCP. </p>\n<p><strong>Primary sclerosing cholangitis </strong>(PSC) is a chronic progressive disorder characterized by <strong>inflammation</strong> and <strong>fibrosis</strong> of <strong>intra and extrahepatic biliary ducts</strong> resulting in strictures and cholestasis. The cause is unknown. Most patients have underlying <strong>ulcerative colitis. </strong>It has an association with <strong>HLA DRw52</strong>. Patients present with symptoms of cholestasis such as fatigue and pruritus. </p>\n<p>The laboratory findings include:</p>\n<ul>\n<li>Liver function tests - Elevated ALP and aminotransferases.</li>\n<li>Increased serum IgM levels</li>\n<li><strong>Positive p-ANCA</strong></li>\n</ul>\n<p><strong>MRCP</strong> is the <strong>investigation of choice</strong>. It shows multiple strictures in intra and extrahepatic bile ducts. Liver <strong>biopsy</strong> reveals a concentric <strong>\"onion skin\" fibrosis. </strong>This is however not pathognomic of PSC. </p>\n<p>There is no definitive treatment. It involves the administration of UDCA and <strong>liver transplantation. </strong></p>\n<p>PSC can lead to the development of <strong>cholangiocarcinoma</strong></p>\n<p>The image below shows onion-skin fibrosis in PSC.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4d9dd76ef1104b139a9a0c337bef4888x754x600.PNG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Differences between primary sclerosing cholangitis (PSC)  and primary biliary cholangitis (PBC)</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Primary Biliary Cholangitis</strong></td>\n<td><strong>Primary Sclerosing Cholangitis</strong></td>\n</tr>\n<tr>\n<td>Antibodies</td>\n<td>\n<p>Antimitochondrial antibodies positive in most patients</p>\n<p>Antinuclear antibodies positive</p>\n</td>\n<td>\n<div class=\"page\" title=\"Page 860\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Antimitochondrial antibodies /AMA typically negative</p>\n</div>\n</div>\n</div>\n</div>\n<p><strong>p-ANCA</strong>-positive</p>\n</td>\n</tr>\n<tr>\n<td>Age group</td>\n<td>40&ndash;60 years</td>\n<td>30-45 years</td>\n</tr>\n<tr>\n<td>Gender predominance</td>\n<td>Females</td>\n<td>Males</td>\n</tr>\n<tr>\n<td>Site</td>\n<td>Intrahepatic&nbsp;bile ducts only</td>\n<td>Intra- and extrahepatic bile ducts</td>\n</tr>\n<tr>\n<td>&nbsp;Associated with</td>\n<td>\n<p>Sjogren syndrome</p>\n<p>Hashimoto's thyroiditis&nbsp;</p>\n<p>CREST&nbsp;syndrome</p>\n<p>Rheumatoid arthritis</p>\n<p>Celiac disease</p>\n</td>\n<td><strong>Ulcerative colitis</strong></td>\n</tr>\n<tr>\n<td>Diagnosis</td>\n<td>Biopsy</td>\n<td>MRCP/ERCP-strictures&nbsp;</td>\n</tr>\n<tr>\n<td>Biopsy findings</td>\n<td>&nbsp;<strong>Florid duct lesion</strong> (granuloma)</td>\n<td>Concentric \"<strong>onion-skin\"</strong>&nbsp;fibrosis &nbsp; &nbsp;</td>\n</tr>\n<tr>\n<td>Long-term complication</td>\n<td>Cirrhosis</td>\n<td>\n<p>Cirrhosis</p>\n<p>Cholangiocarcinoma</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1181",
      "difficulty": "medium"
    }
  ]
}